ardent health inc - ARDT

ARDT

Close Chg Chg %
8.96 0.09 1.00%

Pre-Market

9.05

+0.09 (1.00%)

Volume: 475.81K

Last Updated:

Dec 30, 2025, 3:59 PM EDT

Company Overview: ardent health inc - ARDT

ARDT Key Data

Open

$8.95

Day Range

8.92 - 9.13

52 Week Range

8.28 - 17.29

Market Cap

$1.28B

Shares Outstanding

143.19M

Public Float

23.22M

Beta

0.76

Rev. Per Employee

N/A

P/E Ratio

6.39

EPS

$1.45

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

554.57K

 

ARDT Performance

1 Week
 
-1.95%
 
1 Month
 
2.96%
 
3 Months
 
-35.52%
 
1 Year
 
-47.07%
 
5 Years
 
N/A
 

ARDT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 13
Full Ratings ➔

About ardent health inc - ARDT

Ardent Health, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals through its subsidiaries. The company was founded in 1993 and is headquartered in Brentwood, TN.

ARDT At a Glance

Ardent Health, Inc.
340 Seven Springs Way
Brentwood, Tennessee 37027
Phone 1-615-296-3000 Revenue 5.97B
Industry Hospital/Nursing Management Net Income 210.34M
Sector Health Services 2024 Sales Growth 10.289%
Fiscal Year-end 12 / 2025 Employees 24,900
View SEC Filings

ARDT Valuation

P/E Current 6.208
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.591
Price to Sales Ratio 0.409
Price to Book Ratio 2.155
Price to Cash Flow Ratio 7.74
Enterprise Value to EBITDA 8.089
Enterprise Value to Sales 0.763
Total Debt to Enterprise Value 0.501

ARDT Efficiency

Revenue/Employee 239,601.285
Income Per Employee 8,447.51
Receivables Turnover 7.965
Total Asset Turnover 1.144

ARDT Liquidity

Current Ratio 1.939
Quick Ratio 1.817
Cash Ratio 0.589

ARDT Profitability

Gross Margin 97.548
Operating Margin 6.986
Pretax Margin 6.085
Net Margin 3.526
Return on Assets 4.033
Return on Equity 23.342
Return on Total Capital 6.162
Return on Invested Capital 6.61

ARDT Capital Structure

Total Debt to Total Equity 201.718
Total Debt to Total Capital 66.856
Total Debt to Total Assets 42.837
Long-Term Debt to Equity 196.802
Long-Term Debt to Total Capital 65.227
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Ardent Health Inc - ARDT

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
4.87B 5.13B 5.41B 5.97B
Sales Growth
+17.02% +5.32% +5.45% +10.29%
Cost of Goods Sold (COGS) incl D&A
137.20M 138.17M 140.84M 146.29M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
137.20M 138.17M 140.84M 146.29M
Depreciation
137.20M 138.17M 140.84M 146.29M
Amortization of Intangibles
- - - -
-
COGS Growth
- +0.71% +1.93% +3.87%
Gross Income
4.73B 4.99B 5.27B 5.82B
Gross Income Growth
- +5.46% +5.55% +10.46%
Gross Profit Margin
+97.18% +97.31% +97.40% +97.55%
2021 2022 2023 2024 5-year trend
SG&A Expense
4.04B 4.33B 4.59B 4.91B
Research & Development
- - - -
-
Other SG&A
4.04B 4.33B 4.59B 4.91B
SGA Growth
+4.10% +7.15% +5.99% +6.96%
Other Operating Expense
371.16M 464.46M 451.80M 496.21M
Unusual Expense
(60.10M) (17.87M) 5.26M 14.40M
EBIT after Unusual Expense
382.83M 216.98M 224.25M 402.38M
Non Operating Income/Expense
17.62M 180.15M (14.53M) 7.25M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
104.56M 85.64M 58.10M 46.57M
Interest Expense Growth
-7.85% -18.09% -32.16% -19.85%
Gross Interest Expense
104.56M 85.64M 58.10M 46.57M
Interest Capitalized
- - - -
-
Pretax Income
295.89M 311.48M 151.61M 363.06M
Pretax Income Growth
+358.16% +5.27% -51.32% +139.46%
Pretax Margin
+6.08% +6.07% +2.80% +6.09%
Income Tax
51.31M 46.11M 22.64M 63.35M
Income Tax - Current - Domestic
81.96M (8.00K) 17.88M 40.07M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(30.65M) 46.12M 4.75M 23.28M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
244.58M 265.37M 128.98M 299.71M
Minority Interest Expense
90.32M 76.46M 75.07M 89.36M
Net Income
154.26M 188.91M 53.90M 210.34M
Net Income Growth
+207.85% +22.46% -71.47% +290.22%
Net Margin Growth
+3.17% +3.68% +1.00% +3.53%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
154.26M 188.91M 53.90M 210.34M
Preferred Dividends
- - - -
-
Net Income Available to Common
154.26M 188.91M 53.90M 210.34M
EPS (Basic)
1.0767 1.3186 0.3763 1.4735
EPS (Basic) Growth
- +22.47% -71.46% +291.58%
Basic Shares Outstanding
143.26M 143.26M 143.26M 142.75M
EPS (Diluted)
1.0767 1.3186 0.3763 1.4735
EPS (Diluted) Growth
- +22.47% -71.46% +291.58%
Diluted Shares Outstanding
143.26M 143.26M 143.26M 142.75M
EBITDA
459.93M 337.28M 370.35M 563.07M
EBITDA Growth
+63.19% -26.67% +9.80% +52.04%
EBITDA Margin
+9.44% +6.58% +6.85% +9.44%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 13.833
Number of Ratings 13 Current Quarters Estimate 0.225
FY Report Date 03 / 2026 Current Year's Estimate 1.376
Last Quarter’s Earnings 0.33 Median PE on CY Estimate N/A
Year Ago Earnings 1.127 Next Fiscal Year Estimate 1.511
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 9 11 8
Mean Estimate 0.23 0.40 1.38 1.51
High Estimates 0.36 0.53 1.90 2.10
Low Estimate 0.16 0.32 1.09 1.16
Coefficient of Variance 29.26 20.65 17.25 21.33

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 10
OVERWEIGHT 0 0 0
HOLD 4 4 1
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Buy

Insider Actions for Ardent Health Inc - ARDT

Date Name Shares Transaction Value
Apr 7, 2025 Robert A. DeMichiei Director 10,073 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Ardent Health Inc in the News